Join Dr. Gül Dölen, an associate professor at Johns Hopkins University and a trailblazer in psychedelic research, as she explores groundbreaking applications for psychedelics. She discusses how these substances could reopen critical periods in the brain for disorders like autism and stroke, revealing their potential as therapeutic 'master keys.' Fascinating insights into octopuses under the influence and the intricate link between the brain and immune response further highlight the transformative power of psychedelics in health and learning.

In a captivating discussion, Gül Dölen, a pioneering neuroscientist from Johns Hopkins University, delves into the fascinating world of psychedelics and their impact on mental health. She explains how substances like LSD and psilocybin open critical periods in brain development, enhancing social learning and plasticity. Gül contrasts these non-addictive drugs with traditional addictions, emphasizing their potential for therapeutic applications. The conversation also highlights the evolving landscape of psychiatry and the need for context in psychedelic treatments.

Gül Dölen, a neuroscientist and psychiatric researcher at UC Berkeley, explores the groundbreaking potential of psychedelics in treating mental health issues like addiction and PTSD. She shares how these substances can rewire brain pathways, reopening critical periods essential for learning and adaptation. The conversation dives into the evolving attitudes within the scientific community, highlighting both the challenges and the excitement surrounding psychedelic research. Dölen's insights pave the way for a future where psychedelics could revolutionize mental health treatment.